Respiratory syncytial virus (RSV) immunisation RSV prevention resources and data to assist healthcare providers and the general public RSV – frequently asked questions (FAQs) RSV immunisation products – evaluation and expected access RSV immunisation products – efficacy and safety NCIRS webinar: RSV and older adults NCIRS webinar: RSV and infants Useful links ATAGI statement on nirsevimab 2024 – Australian Government Department of Health and Aged CareATAGI statement on the clinical use of Arexvy (RSV PRE-F3) vaccine for RSV – Australian Government Department of Health and Aged CareArexvy: Australian prescription medicine decision summary – TGABeyfortus: Australian prescription medicine decision summary – TGABeyfortus (nirsevimab) guidance:NSW HealthQueensland HealthWA HealthRSV clinical trial tracker – PATH News & events News | 30 April 2024 World Immunization Week 2024 – 50 years of global progress News | 24 April 2024 NCIRS celebrates World Immunization Week 2024 News | 27 March 2024 NCIRS releases new and updated FAQs resources News | 08 March 2024 International Women’s Day reflection 242 views